# EVOXAC
> **NDA221183** · New Drug Application · Sponsor: COSETTE PHARMS NC · Approved 2026-10-15
## Drug
- **FDA Application Number:** NDA221183
- **Application type:** New Drug Application
- **Brand name:** EVOXAC
- **Generic name:** Cevimeline Hydrochloride
- **Active ingredients:** CEVIMELINE HYDROCHLORIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** COSETTE PHARMS NC
- **First approval:** 2026-10-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221183)
---
*MORVS · CC0 1.0*